Original Article
Modern Pathology (2008) 21, 334–344; doi:10.1038/modpathol.3801009; published online 11 January 2008
Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma
Maurits N C de Koning1, Wim G V Quint1 and Edyta C Pirog2
- 1DDL Diagnostic Laboratory, Voorburg, The Netherlands
- 2Department of Pathology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, NY, USA
Correspondence: Dr EC Pirog, MD, Department of Pathology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 E 68th Street, F-766, New York, NY 10065-4897, USA. E-mail: ecpirog@med.cornell.edu
Received 10 October 2007; Revised 19 November 2007; Accepted 26 November 2007; Published online 11 January 2008.
Abstract
Two independent pathways of vulvar carcinogenesis have currently been identified, one related to infection with mucosal human papillomaviruses (HPVs) and a second related to chronic inflammatory or autoimmune processes. The goal of the study was to examine a possible role of cutaneous HPVs from the beta genus in vulvar carcinogenesis and to evaluate the distribution of intratypic variants of HPV 16 in HPV 16-positive vulvar cancer. Consecutive cases of vulvar carcinoma were retrieved from the files and included the following histologic subtypes: keratinizing (n=21), basaloid (n=7), warty (n=1), mixed basaloid–warty (n=4), verrucous (n=4), keratoacanthoma (n=1), basal cell carcinoma (n=1). All tumors were microdissected and tested for 25 beta HPV types and 25 mucosal HPV types. Cases identified as positive for HPV 16 were further tested for intratypic variants. All cases were immunostained for p16INK4a. Beta HPVs were not detected in any of the tumor cases. Mucosal HPVs were detected in all but one basaloid/warty carcinomas; of these, nine cases (82%) were positive for HPV 16, including five European subtypes, one African subtype, one North American subtype and two indeterminate subtypes. Two of four verrucous carcinomas were positive for HPV 6. Mucosal HPVs were not detected in keratinizing carcinomas, keratoacanthoma and basal cell carcinoma. All cases of basaloid/warty carcinomas, but none of the remaining tumors, overexpressed p16INK4a protein. Our data do not support a role of beta HPVs in the pathogenesis of vulvar carcinoma. The study reaffirms the role of mucosal HPVs, in particular that of HPV 16, in the pathogenesis of basaloid and warty tumor subtypes. The HPV 16 intratypic variation showed correlation with patients' ethnic background. P16INK4a immunostaining seems to be a sensitive and specific marker of vulvar carcinomas positive for oncogenic mucosal HPVs.
Keywords:
vulvar carcinoma, HPV, P16INK4a
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva
Modern Pathology Original Article
HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis
Modern Pathology Original Article
MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva
Modern Pathology Original Article
Modern Pathology Original Article

